title: Anti-Staphylococcus aureus immunotherapy: current status and prospects.
abstract: Immunological prophylaxis and therapy for Staphylococcus aureus are attractive goals. However, there is nothing currently available in the clinic. Several approaches have failed and more are being undertaken. Here we assess current progress and the potential for success.
authors.affiliation: Absynth Biologics Ltd, The Bioincubator, Sheffield S3 7RD, UK.
authors.forename: Jorge
authors.initials: J
authors.lastname: García-Lara
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Foster
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D018579:Patient Selection; D013203:Staphylococcal Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy*; D013209:Staphylococcal Vaccines / Q000737:chemistry; D013211:Staphylococcus aureus / Q000276:immunology* / Q000472:pathogenicity; D017211:Treatment Failure
chemical_list: D013209:Staphylococcal Vaccines